The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

The study, which was simultaneously published in Circulation and presented as a Late-Breaking Clinical Trial at the American Heart Association Scientific Sessions, marked a significant step toward ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

Long Beach Medical Center Cardiologists Pioneer Innovative Use of GLP-1 Agonists For decades, GLP-1 agonists—a class of medications including generic names like semaglutide and tirzepatide—have been ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab ...